Oxylipins in Aqueous Humor of Primary Open-Angle Glaucoma Patients.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
05 Sep 2024
Historique:
received: 23 07 2024
revised: 31 08 2024
accepted: 04 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Investigate the oxylipin profiles in the aqueous humor of primary open-angle glaucoma (POAG) patients. Aqueous humor samples were collected from 17 POAG patients and 15 cataract subjects and subjected to a liquid chromatography/mass spectrometry (LC-MS) analysis to detect the oxylipins. The prediction potential of the differential abundant oxylipins was assessed by the receiver operating characteristic (ROC) curves. Pathway and correlation analyses on the oxylipins and clinical and biochemical parameters were also conducted. The LC-MS analysis detected a total of 76 oxylipins, of which 29 oxylipins reached the detection limit. The multivariate analysis identified five differential abundant oxylipins, 15-keto-prostaglandin F2 alpha (15-kPGF2α), Leukotriene B4 (LTB4), 12,13-Epoxyoctadecenoic acid (12,13-Epome), 15-Hydroxyeicosatetraenoic acid (15-HETE) and 11-Hydroxyeicosatetraenoic acid (11-HETE). The five oxylipins are enriched in the arachidonic acid metabolism and linoleic acid metabolism pathways. Pearson correlation analysis showed that 11-HETE was positively correlated with intraocular pressure and central corneal thickness and negatively with cup/disk area ratio in the POAG patients. In addition, 15-kPGF2α was moderately and positively correlated with the mean deviation (MD) of visual field defect, and LTB4 was moderately and negatively correlated with macular thickness. This study revealed the oxylipin profile in the aqueous humor of POAG patients. Oxylipins involved in the arachidonic acid metabolism pathway could play a role in POAG, and anti-inflammatory therapies could be potential treatment strategies for POAG.

Identifiants

pubmed: 39334893
pii: biom14091127
doi: 10.3390/biom14091127
pii:
doi:

Substances chimiques

Oxylipins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 82171044
Organisme : Natural Science Foundation of Guangdong Province
ID : 2022A1515011646

Auteurs

Jianming Xu (J)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Shantou University Medical College, Shantou 515041, China.

Kewen Zhou (K)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Shantou University Medical College, Shantou 515041, China.

Changzhen Fu (C)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.

Chong-Bo Chen (CB)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.

Yaru Sun (Y)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Shantou University Medical College, Shantou 515041, China.

Xin Wen (X)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Shantou University Medical College, Shantou 515041, China.

Luxi Yang (L)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Shantou University Medical College, Shantou 515041, China.

Tsz-Kin Ng (TK)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong.

Qingping Liu (Q)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Guangdong-Hong Kong-Macao University Joint Research Laboratory of Precision Prevention and Treatment on Ocular Diseases, Shantou 515041, China.
Guangdong Provincial Engineering Technology Research Center for Precision Diagnosis and Treatment on Ocular Diseases of Guangdong Province, Shantou 515041, China.

Mingzhi Zhang (M)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Guangdong-Hong Kong-Macao University Joint Research Laboratory of Precision Prevention and Treatment on Ocular Diseases, Shantou 515041, China.
Guangdong Provincial Engineering Technology Research Center for Precision Diagnosis and Treatment on Ocular Diseases of Guangdong Province, Shantou 515041, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH